GGrantIndex
Sort

40,608 grants matching prostate cancer

SPORE in Prostate Cancer

$2,513,374
Mayo Clinic Coll Of Medicine, Rochester · P50 · FY2003 · CA

PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREENING

$2,501,456
Paul A Kvale · · N01 · FY2007 · CA

Bioengineered Antibodies in Cancer Imaging and Therapy

$2,500,917
City Of Hope/Beckman Research Institute · P01 · FY2003 · CA

CHEMOIMMUNOTHERAPY FOR AGGRESSIVE VARIANT PROSTATE CANCERS (AVPC)

$2,498,000
The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2020 · Defense Health Agency

Identifying Diagnostic Markers for Cervical, Breast, and Prostate Cancer

$2,495,409
Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Cancer Risk in Human Populations

$2,493,437
Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

Center for Cell-based Therapy - Cures

$2,493,170
Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Cancer Epidemiology Cohort in Male Health Professionals

$2,483,787
Walter C. Willett · Harvard School Of Public Health · UM1 · FY2015 · CA

(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank

$2,481,702
Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2022 · CA

Federated Deep Learning to Accelerate Alzheimer's Disease Research

$2,477,877
Paul M Thompson · University Of Southern California · RF1 · FY2025 · AG

SPORE in Prostate Cancer

$2,476,722
Mayo Clinic · P50 · FY2004 · CA

The Role of TIMPs in Cell Growth and Differentiation: Tumor Angiogenesis

$2,474,858
William G Stetler-Stevenson · Division Of Clinical Sciences - Nci · Z01 · FY2008 · CA

Contraceptive Discovery, Development and Behavioral Research Center

$2,473,290
Gunda I. Georg · University Of Minnesota · U54 · FY2017 · HD

Cancer Risk in Human Populations

$2,471,847
Debra Silverman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

SPORE in Prostate Cancer

$2,471,062
Dana-Farber Cancer Institute · P50 · FY2002 · CA

OPTIMIZATION OF HIGH DOSE CONFORMAL THERAPY

$2,470,329
University Of Michigan At Ann Arbor · P01 · FY2004 · CA

(EET Biobank) NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank

$2,467,614
Kathleen Nicol · Research Inst Nationwide Children'S Hosp · U24 · FY2023 · CA

Center for Pre-Clinical Cancer Research

$2,467,250
Joseph Francis · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM

UCCRC--CANCER CENTER SUPPORT GRANT

$2,466,698
University Of Chicago · P30 · FY2000 · CA

University of Texas SPORE in Prostate Cancer

$2,465,849
University Of Texas Md Anderson Can Ctr · P50 · FY2003 · CA

GENETIC AND EPIGENETIC PROSTATE CANCER-RELATED ALTERATIONS IN EARLY ONSET DISEASE IN AFRICAN AMERICAN MEN

$2,465,451
Health Research, Inc. · · FY2017 · Department of the Army

DF/HCC SPORE in Prostate Cancer

$2,463,000
Philip W Kantoff · Dana-Farber Cancer Inst · P50 · FY2009 · CA

DF/HCC SPORE in Prostate Cancer

$2,463,000
Philip W Kantoff · Dana-Farber Cancer Inst · P50 · FY2008 · CA

DF/HCC SPORE in Prostate Cancer

$2,461,000
Philip W Kantoff · Dana-Farber Cancer Inst · P50 · FY2007 · CA

Convergent Epigenetic Control of Neuroendocrine Cancers

$2,452,400
James A Decaprio · Dana-Farber Cancer Inst · P01 · FY2025 · CA